Zobrazeno 1 - 10
of 15
pro vyhledávání: ''
Autor:
Akihito Tsuji, Satoshi Kaihara, Michio Inukai, Takanori Watanabe, Toshihiko Matsumoto, Masahito Kotaka, Hiroki Hashida, Yasuhiro Miyake, Hiroaki Tanioka, Hisateru Yasui, Masato Matsuura, Shinichi Yoshioka, Yoshihiro Okita, Takeshi Kotake, Takahisa Kyogoku, Takeshi Kato, Hironaga Satake
Publikováno v:
The Oncologist
Lessons Learned Background The role of neoadjuvant and adjuvant chemotherapy in the management of initially resectable colorectal cancer liver metastases (CLM) is still unclear. We evaluated the feasibility of 3-month adjuvant treatment with capecita
Publikováno v:
The Oncologist
Trial Information Click here to access other published clinical trials. Lessons Learned Studies targeting cladribine in combination with granulocyte colony-stimulating factor, low-dose cytarabine, and aclarubicin (C-CAG) regimen in relapsed and refra
Autor:
Christina Cox, Michele Spina, Samantha Ferrari, Luigi Rigacci, Francesco Merli, Francesco Angrilli, Silvia Bolis, Antonino Mulè, Stefano Luminari, Maria Luigia Vigliotti, Ombretta Annibali, Pier Luigi Zinzani, Samantha Pozzi, Guido Gini, Elisabetta Bonifacio, Francesca Pregnolato, Serena Broggi, S. Kovalchuk, Scalzulli Rp, Angela Maria Mamusa, Armando Santoro, Gloria Margiotta-Casaluci, L. Flenghi, Umberto Vitolo, Fondazione Italiana Linfomi
Publikováno v:
Hematological Oncology
Doxorubicin is the most effective single agent in the treatment of non‐Hodgkin's lymphoma (NHL). Its use is limited because of the cardiac toxicity primarily in elderly patients (pts) and in pts with history of cardiac disease. Liposomal doxorubici
Autor:
Pradip Devhare, Rajan Datar, Sewanti Limaye, Madhavi Apastamb, Ajay Srinivasan, S. Pawar, Tim Crook, Pooja Fulmali, Shoeb Patel, Sanket Patil, Cynthe Sims, Vineet Datta, Raymond L. Page, Archana Adhav, Navin Srivastava, Sachin Apurwa, Anantbhushan Ranade, Pradeep Fulmali, Dadasaheb Akolkar, Rohit Chougule, Akshay Ainwale, Revati Patil, Darshana Patil
Publikováno v:
International Journal of Cancer
Circulating ensembles of tumor‐associated cells (C‐ETACs) which comprise tumor emboli, immune cells and fibroblasts pose well‐recognized risks of thrombosis and aggressive metastasis. However, the detection, prevalence and characterization of C
Autor:
Kotaro Ozasa, Mai Utada, Alina V. Brenner, Munechika Misumi, Dale L. Preston, Ritsu Sakata, Kiyohiko Mabuchi, Atsuko Sadakane, Hiromi Sugiyama, Eric J. Grant
Publikováno v:
International Journal of Cancer
Radiation effects on colorectal cancer rates, adjusted for smoking, alcohol intake and frequency of meat consumption and body mass index (BMI) by anatomical subsite (proximal colon, distal colon and rectum) were examined in a cohort of 105,444 atomic
Autor:
Timothy W. Synold, Joseph Chao, Marwan Fakih, May Cho, Vincent Chung, Rohan Gupta, Paul Frankel, Jun Gong, Dean Lim, Christopher Ruel
Publikováno v:
The Oncologist
Vinorelbine tartrate is a semi‐synthetic vinca alkaloid and an inhibitor of microtubule polymerization with demonstrated antitumor properties across a spectrum of cancers. The pharmacokinetics of vinorelbine may be altered in individuals with liver
Publikováno v:
The Oncologist
This article reports on the association between phase angle, which is measured by bioelectric impedance analysis and reflects cellular integrity and hydration level, and survival in patients with advanced cancer.
Background. Phase angle is a pro
Background. Phase angle is a pro
Autor:
Shubham Pant, Samuel McNeely, Ling Gao, Mansoor N. Saleh, Roberto Carlesi, Van K. Morris, C. Terret, Huzhang Mao, Philippe A. Cassier, Amanda Long, Siqing Fu, Lauriane Eberst, Gurudatta Naik, Erin K. Wagner
Publikováno v:
Oncologist
Trial Information Click here to access other published clinical trials. Lessons Learned The combination of the antivascular endothelial growth factor receptor 2 monoclonal antibody, ramucirumab, and the type II MET kinase inhibitor, merestinib, is to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6da28aca92f18edeb01b84065f999b
https://europepmc.org/articles/PMC7648328/
https://europepmc.org/articles/PMC7648328/
Autor:
Bassel F. El-Rayes, Walid L. Shaib, Madhusmita Behera, Olatunji B. Alese, Renjian Jiang, Mehmet Akce, Christina Wu
Publikováno v:
Oncologist
BACKGROUND. High‐grade neuroendocrine carcinomas are rare in the gastrointestinal tract. However, treatment patterns and outcomes have not been well described. SUBJECTS, MATERIALS, AND METHODS. The National Cancer Database was analyzed. The primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5650aaea4bf34b91157d460f6c5dca4
https://europepmc.org/articles/PMC7216443/
https://europepmc.org/articles/PMC7216443/
Background Patients with advanced lung neuroendocrine neoplasms (NENs) have few treatment options. Capecitabine and temozolomide have recently showed significant activity in patients with pancreatic neuroendocrine tumors (NETs), but data in lung NETs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d30fc71cc5c6aa879db135bc25b5b6a
https://europepmc.org/articles/PMC6964126/
https://europepmc.org/articles/PMC6964126/